Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Cecilia Low Wang

Concepts (207)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperglycemia
8
2024
325
2.570
Why?
Diabetes Mellitus, Type 2
16
2025
2430
2.080
Why?
Blood Glucose
14
2025
2092
1.500
Why?
Diabetes Mellitus
7
2021
1001
1.330
Why?
Lower Extremity
4
2024
404
1.230
Why?
Cardiovascular System
2
2019
139
1.060
Why?
Hypoglycemic Agents
7
2025
1214
1.030
Why?
Peripheral Arterial Disease
4
2024
458
1.010
Why?
Platelet Aggregation Inhibitors
3
2024
439
0.960
Why?
Cardiovascular Diseases
7
2024
2018
0.960
Why?
Prediabetic State
2
2024
245
0.880
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2022
411
0.700
Why?
Blood Glucose Self-Monitoring
3
2025
599
0.690
Why?
Epidemics
1
2021
79
0.670
Why?
Aspirin
2
2024
378
0.650
Why?
Hypoglycemia
1
2024
426
0.630
Why?
Insulin Resistance
7
2024
1166
0.620
Why?
Drug Approval
1
2019
86
0.610
Why?
Early Termination of Clinical Trials
1
2018
15
0.600
Why?
Glucocorticoids
3
2022
575
0.590
Why?
Physicians, Primary Care
1
2021
227
0.590
Why?
Sample Size
1
2018
115
0.580
Why?
Clinical Trials as Topic
2
2019
998
0.550
Why?
Insulin
10
2024
2318
0.520
Why?
Atherosclerosis
3
2017
405
0.510
Why?
Ischemia
1
2018
395
0.490
Why?
Electron Transport Complex I
1
2015
38
0.490
Why?
Drugs, Investigational
1
2015
32
0.480
Why?
Hospitals
2
2017
631
0.480
Why?
Patient Care Planning
1
2016
148
0.470
Why?
Patient Selection
1
2018
661
0.450
Why?
Endovascular Procedures
1
2018
303
0.430
Why?
Algorithms
2
2023
1616
0.420
Why?
Swine, Miniature
1
2013
78
0.410
Why?
Insulin, Long-Acting
2
2024
61
0.410
Why?
Drug Delivery Systems
1
2015
326
0.390
Why?
Hospitalization
3
2025
2071
0.350
Why?
Glucose
3
2024
983
0.330
Why?
Obesity
6
2023
2860
0.330
Why?
Humans
36
2025
128524
0.330
Why?
Enteral Nutrition
3
2024
184
0.330
Why?
Insulin, Isophane
2
2024
20
0.330
Why?
Metabolic Syndrome
1
2013
340
0.320
Why?
Diabetes Complications
2
2013
224
0.270
Why?
Muscle, Smooth, Vascular
3
2007
417
0.250
Why?
Dietary Fats
3
2012
301
0.220
Why?
Myocytes, Smooth Muscle
2
2006
245
0.210
Why?
Factor Xa Inhibitors
1
2024
169
0.210
Why?
Heart Failure
1
2016
2150
0.210
Why?
Treatment Outcome
5
2019
10163
0.200
Why?
Glucose Intolerance
1
2024
142
0.200
Why?
Endocrinology
1
2023
74
0.200
Why?
Rivaroxaban
1
2024
254
0.200
Why?
Diet
3
2015
1200
0.190
Why?
Steroids
1
2022
148
0.190
Why?
Postoperative Complications
2
2024
2479
0.190
Why?
Glucagon-Like Peptide-1 Receptor
1
2022
91
0.190
Why?
Risk Factors
5
2019
9727
0.180
Why?
Dyslipidemias
1
2023
177
0.180
Why?
Patient Admission
1
2012
184
0.180
Why?
Male
17
2025
62883
0.170
Why?
Dexamethasone
1
2022
336
0.170
Why?
Anticholesteremic Agents
2
2017
146
0.170
Why?
Female
18
2025
68127
0.170
Why?
Fatty Acids, Monounsaturated
2
1998
51
0.160
Why?
Diet, Reducing
2
1998
84
0.160
Why?
Diabetic Angiopathies
1
2011
263
0.160
Why?
Dietary Carbohydrates
4
2012
152
0.160
Why?
Middle Aged
12
2025
30893
0.150
Why?
Inpatients
1
2012
460
0.150
Why?
Double-Blind Method
2
2024
1860
0.150
Why?
Critical Illness
1
2024
729
0.150
Why?
Fellowships and Scholarships
1
2021
273
0.140
Why?
United States
5
2023
13876
0.140
Why?
Aged
7
2025
21971
0.140
Why?
Hypercholesterolemia
1
2017
101
0.130
Why?
Dose-Response Relationship, Drug
3
2015
1943
0.130
Why?
Insulin Receptor Substrate Proteins
2
2013
60
0.130
Why?
Quality of Health Care
1
2021
607
0.130
Why?
Early Growth Response Protein 1
1
2006
26
0.130
Why?
Diet, Diabetic
1
1996
35
0.130
Why?
Electronic Health Records
1
2023
967
0.130
Why?
Medical Staff, Hospital
1
2016
79
0.130
Why?
Nausea
1
2015
108
0.120
Why?
Cardiovascular Physiological Phenomena
1
2004
44
0.120
Why?
Mexican Americans
1
2015
113
0.120
Why?
Caloric Restriction
2
2012
108
0.120
Why?
Physicians
1
2023
860
0.110
Why?
MAP Kinase Signaling System
1
2006
302
0.110
Why?
Biomarkers
3
2023
3881
0.110
Why?
Hypertension
1
2023
1238
0.110
Why?
Adiponectin
1
2015
234
0.110
Why?
Quality of Life
2
2023
2680
0.110
Why?
Dehydroepiandrosterone
1
2004
51
0.110
Why?
Lactic Acid
1
2015
295
0.110
Why?
Signal Transduction
4
2012
4829
0.100
Why?
Cystic Fibrosis
1
2012
1057
0.100
Why?
Androgens
1
2004
174
0.100
Why?
Muscle, Skeletal
2
2012
1639
0.100
Why?
Sirtuin 1
1
2012
30
0.100
Why?
Nitric Oxide Synthase Type III
1
2013
201
0.100
Why?
Disease Management
1
2016
588
0.100
Why?
Parenteral Nutrition
1
2013
108
0.100
Why?
Weight Loss
2
1998
723
0.100
Why?
Phosphorylation
2
2013
1681
0.090
Why?
Postmenopause
1
2004
370
0.090
Why?
Patient Care Team
1
2016
600
0.090
Why?
Arteries
1
2013
266
0.090
Why?
Renal Insufficiency
1
2013
148
0.090
Why?
Retrospective Studies
3
2024
14460
0.090
Why?
Estrogens
1
2004
354
0.090
Why?
Adiposity
1
2015
505
0.090
Why?
AMP-Activated Protein Kinases
1
2012
190
0.090
Why?
Swine
1
2013
743
0.090
Why?
Oxidative Stress
1
2006
1188
0.080
Why?
Risk Assessment
1
2019
3256
0.080
Why?
Vasodilation
1
2013
478
0.080
Why?
Renal Dialysis
1
2013
420
0.080
Why?
Insulin Infusion Systems
2
2012
362
0.080
Why?
Gene Expression Regulation
1
2006
2506
0.070
Why?
Cognition
1
2004
1107
0.060
Why?
Phosphates
1
2007
167
0.060
Why?
Cholesterol, LDL
2
2017
361
0.060
Why?
Endocrinologists
1
2023
12
0.050
Why?
Disease Models, Animal
1
2013
3943
0.050
Why?
Nonlinear Dynamics
1
2023
88
0.050
Why?
Glucose Tolerance Test
1
2024
356
0.050
Why?
Analysis of Variance
2
2004
1271
0.050
Why?
Injections, Subcutaneous
1
2012
145
0.050
Why?
Exercise Tolerance
1
2024
269
0.050
Why?
Insulin Glargine
1
2012
80
0.050
Why?
Frailty
1
2024
149
0.050
Why?
Albuminuria
1
2012
181
0.050
Why?
Vascular Surgical Procedures
1
2024
293
0.050
Why?
Drug Therapy, Combination
1
2024
1009
0.050
Why?
Adult
7
2016
35315
0.050
Why?
Animals
5
2013
34501
0.050
Why?
Phosphatidylinositol 3-Kinases
2
2012
357
0.040
Why?
Phenotype
2
2023
3050
0.040
Why?
Cells, Cultured
3
2007
4008
0.040
Why?
Calcium
1
2007
1178
0.040
Why?
Prospective Studies
2
2021
7043
0.040
Why?
Adolescent
2
2015
20213
0.040
Why?
Aged, 80 and over
2
2024
7040
0.040
Why?
C-Peptide
2
1998
163
0.040
Why?
Global Health
1
2021
326
0.040
Why?
Antihypertensive Agents
1
2012
486
0.040
Why?
Intensive Care Units
1
2023
718
0.040
Why?
Overweight
1
2023
525
0.040
Why?
Exercise Therapy
1
2012
414
0.040
Why?
Dietary Fats, Unsaturated
1
1998
23
0.040
Why?
Cholesterol
2
1998
406
0.040
Why?
Triglycerides
2
1998
524
0.030
Why?
Enzyme Inhibitors
2
2007
811
0.030
Why?
Plaque, Atherosclerotic
1
2017
55
0.030
Why?
Young Adult
3
2015
12320
0.030
Why?
Survival Rate
1
2021
1872
0.030
Why?
Lipoproteins
1
1998
171
0.030
Why?
Mitogen-Activated Protein Kinase 7
1
2006
21
0.030
Why?
Reproducibility of Results
1
2023
3023
0.030
Why?
Diet Surveys
1
2015
92
0.030
Why?
Glucagon
1
1996
105
0.030
Why?
Mitogen-Activated Protein Kinase 3
1
2006
148
0.030
Why?
Time Factors
2
2006
6503
0.030
Why?
Cholesterol, HDL
1
1996
203
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
269
0.030
Why?
Healthy Volunteers
1
2015
202
0.030
Why?
Incidence
1
2021
2619
0.030
Why?
Lipids
1
1998
624
0.030
Why?
Rats
2
2007
5168
0.030
Why?
Hyperinsulinism
1
2004
119
0.030
Why?
Platelet-Derived Growth Factor
1
2003
89
0.030
Why?
Androstadienes
1
2003
107
0.030
Why?
Helminthiasis
1
1993
11
0.030
Why?
Combined Modality Therapy
1
1996
1209
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2017
759
0.020
Why?
Follow-Up Studies
1
2021
4898
0.020
Why?
Reference Values
1
2004
780
0.020
Why?
Interleukin-4
1
1993
213
0.020
Why?
Glucose Clamp Technique
1
2012
195
0.020
Why?
Mitogen-Activated Protein Kinases
1
2003
313
0.020
Why?
In Vitro Techniques
1
2003
1043
0.020
Why?
Dietary Proteins
1
2012
128
0.020
Why?
Self Report
1
2015
801
0.020
Why?
Immunoglobulin E
1
1993
329
0.020
Why?
PPAR gamma
1
2012
182
0.020
Why?
Psychomotor Performance
1
2004
311
0.020
Why?
Antibodies, Monoclonal
1
2017
1355
0.020
Why?
Cattle
1
2003
962
0.020
Why?
Blotting, Western
1
2012
1168
0.020
Why?
Interferon-gamma
1
1993
761
0.020
Why?
Cell Movement
1
2003
937
0.020
Why?
Transcription Factor Pit-1
1
2007
24
0.020
Why?
Sodium-Phosphate Cotransporter Proteins
1
2007
10
0.020
Why?
Gene Expression
1
2012
1462
0.020
Why?
Colorado
1
2015
4392
0.020
Why?
Diabetes Mellitus, Type 1
1
2012
3618
0.020
Why?
Cross-Sectional Studies
1
2015
5040
0.010
Why?
Risk
1
2007
852
0.010
Why?
Kinetics
1
2007
1616
0.010
Why?
Apolipoproteins
1
1998
38
0.010
Why?
Regression Analysis
1
1998
983
0.010
Why?
Energy Intake
1
1998
453
0.010
Why?
Antigens, Helminth
1
1993
12
0.010
Why?
Acute Disease
1
1993
968
0.010
Why?
Chronic Disease
1
1993
1701
0.000
Why?
CD4-Positive T-Lymphocytes
1
1993
1046
0.000
Why?
Low Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)